Paper4833656
Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.
Tillement JP and 2 others. Experientia, 1974. Cited by 11 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro. Papers, record 4833656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4833656
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of sodium chlorophenoxyisobutyrate on the binding of vitamin K antagonists to human albumin in vitro.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticoagulants | Major topic |
| Clofibrate | Major topic |
| Serum Albumin | Major topic |
| Vitamin K | Major topic |
| Acenocoumarol | |
| Binding Sites | |
| Ethyl Biscoumacetate | |
| Humans | |
| Phenindione | |
| Protein Binding | |
| Receptors, Drug | |
| Warfarin |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,764,367 | Effect of phenylbutazone on the binding of vitamin K antagonists to albumin. | Eur J Clin Pharmacol | 1973 | https://conductscience.org/library/papers/4764367 | PubMed |
| 2 | 13,940,003 | Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements. | Lancet | 1963 | https://conductscience.org/library/papers/13940003 | PubMed |
| 3 | 4,163,172 | The anticoagulant response to bishydroxycoumarin. II. The effect of D-thyroxine, clofibrate, and norethandrolone. | Clin Pharmacol Ther | 1967 | https://conductscience.org/library/papers/4163172 | PubMed |
| 4 | 5,638,549 | The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids. | Biochem Pharmacol | 1968 | https://conductscience.org/library/papers/5638549 | PubMed |
| 5 | 4,340,370 | Studies on the interaction of warfarin and clofibrate in man. | Thromb Diath Haemorrh | 1972 | https://conductscience.org/library/papers/4340370 | PubMed |
| 6 | 14,100,911 | CLINICAL OBSERVATIONS ON PATIENTS TREATED WITH ATROMID AND ANTICOAGULANTS. | J Atheroscler Res | 1963 | https://conductscience.org/library/papers/14100911 | PubMed |
| 7 | 5,429,179 | Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids. | Clin Pharmacol Ther | 1970 | https://conductscience.org/library/papers/5429179 | PubMed |
| 8 | 13,871,552 | A spectrophotometric method for the estimation of phenindione. | J Pharm Pharmacol | 1962 | https://conductscience.org/library/papers/13871552 | PubMed |
| 9 | 5,143,536 | Competitive binding of free fatty acids and bilirubin to albumin: differences in HBABA dye versus sephadex G-25 interpretation of results. | Clin Biochem | 1971 | https://conductscience.org/library/papers/5143536 | PubMed |
| 10 | 13,841,929 | [Significance of the chemical determination of coumarin derivatives in clinical medicine]. | Rev Hematol | 1959 | https://conductscience.org/library/papers/13841929 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,333,323 | Interactions of some phenylindanedione anticoagulants with human serum albumin. | Eur J Drug Metab Pharmacokinet | 1981 | https://conductscience.org/library/papers/7333323 | PubMed |
| 1,233,224 | Anticoagulant effect and plasma kinetics of fluorophenindione after a single dose in man. | Eur J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/1233224 | PubMed |
| 925,883 | Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin. | J Pharmacokinet Biopharm | 1977 | https://conductscience.org/library/papers/925883 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4833656
GET https://conductscience.org/api/papers/v1/4833656/authors